TP53 and leukemia: The KEGG analysis showed that the upregulated genes in artSMC were enriched in various cancer pathways, including pancreatic, leukemia, thyroid, bladder, endometrial and non-small cell lung cancer, basal cell carcinoma, melanoma, glioma, and the p53 signaling pathway (Figure S7A).